Research output: Chapter in Book/Report/Conference proceedingChapter

17 Scopus citations


Pharmacogenetics is the study of how genetics influences drug treatment outcomes. Much research has been conducted to identify and characterize gene variants that impact the pharmacokinetic and pharmacodynamic aspects of medications used to treat neurologic and psychiatric disorders. This chapter reviews the current state of pharmacogenetic aspects of these treatments. Medications with supporting pharmacogenetic information in product labeling, clinical guidelines, or important mechanistic implications are discussed. At this time, clinically relevant genetic variation in drug metabolizing enzymes may inform drug dosing for a number of medications metabolized in the liver. Additionally, genetic variation in immunological genes may be tested to assess risk for severe hypersensitivity reactions to some anticonvulsant drugs. Finally, a growing body of research highlights that genetic polymorphisms in drug targets may influence symptom response or tolerability to some treatments.

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Number of pages15
StatePublished - 2018

Publication series

NameHandbook of Clinical Neurology
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Bibliographical note

Publisher Copyright:
© 2018 Elsevier B.V.


  • anticonvulsant
  • antidepressant
  • antipsychotic
  • anxiolytic
  • mood stabilizer
  • pharmacogenetics
  • pharmacogenomics


Dive into the research topics of 'Pharmacogenetics'. Together they form a unique fingerprint.

Cite this